Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis
Alejandro Balsa; Petra Díaz del Campo Fontecha; Lucía Silva Fernández; José Valencia Martín; Virginia Nistal Martínez; Fernando León Vázquez; M. Vanesa Hernández Hernández; Héctor Corominas; Rafael Cáliz Cáliz; José María Aguado García; Gloria Candelas Rodríguez; Nora Ibargoyen Roteta; Arturo Martí Carvajal; M. Nieves Plana Farras; Janet Puñal Riobóo; Hye Sang Park; Yolanda Triñanes Pego; Virginia Villaverde García;
Reumatol Clin. 2023;19:533-48
Hospitalization and mortality from COVID-19 of patients with rheumatic inflammatory diseases in Andalusia
Natalia Mena-Vázquez; Sara Manrique Arija; Marta Rojas-Giménez; Enrique Raya-ÿlvarez; María Luisa Velloso-Feijoó; C. López-Medina; Consuelo Ramos-Giraldez; Francisco Javier Godoy-Navarrete; Rocío Redondo-Rodríguez; Alba María Cabezas-Lucena; M. Morales-ÿguila; C.M. Romero-Barco; Antonio Fernández-Nebro;
Reumatol Clin. 2022;18:422-8
Characteristics of patients with immune-mediated inflammatory diseases hospitalized for SARS-CoV-2 infection
Montserrat Robustillo-Villarino; Laura Álvarez-Arroyo; Francisco Javier Carrera-Hueso; Inés Barreda-Altaba; María Nieto-Cid; Ana María Girona-Sanz; David El-Qutob;
Reumatol Clin. 2022;18:331-7